Effective treatment strategies for diabetic foot wounds

Journal of Family Practice

Volumn 49, Issue 11 SUPPL., 2000, Pages

  Millington, J T ^a   Norris, T W ^a  

^a St John's Regional Medical Center   (United States)

Author keywords

Diabetic foot; Patient care team; Wound healing

Indexed keywords

RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB;

AMPUTATION; BIOENGINEERING; DEBRIDEMENT; DIABETIC FOOT; DRUG COST; FOOT ULCER; HUMAN; HUMAN CELL; HUMAN TISSUE; OXYGEN THERAPY; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; REVIEW; WOUND DRESSING; WOUND HEALING;

BANDAGES; COUNSELING; DEBRIDEMENT; DIABETIC FOOT; HUMANS; HYPERBARIC OXYGENATION; INFECTION; PATIENT EDUCATION; PERIPHERAL VASCULAR DISEASES; WOUND HEALING;

EID: 0033724545     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Definitions and guidelines for assessment of wounds and evaluation of healing
2. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds
3. Co-factors in impaired healing
4. Principles of wound healing and wound management
5. The evidence supporting the use of the Semmes-Weinstein Monofilament and other threshold tests for preventing foot ulceration and amputatuion in persons with diabetes
6. Diabetic foot ulcers: Pathogenesis and management
7. Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings
8. Assessing the feet in patients with diabetes
9. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes
10. Risk factors for amputation in diabetic patients: A case-controlled study
11. Peripheral vascular disease and diabetes
12. The epidemiology of diabetic foot problems
13. Wound healing alterations caused by infection
14. Infected pressure and diabetic ulcers
15. Effect of extensive debridement and treatment on the healing diabetic foot ulcer
16. Debridement: An essential step in wound healing
17. Common complications of wound healing: Prevention and management
18. Foundations of good ulcer care
19. Debridement
20. The role of diabetic neuropathy and high plantar pressures in the pathogenesis of foot ulceration
21. Evidence-based options for offloading diabetic wounds
22. Reducing dynamic foot pressures in high-risk diabetic subjects with toot ulcerations: A comparison of treatments
23. Decreasing incidence of major amputation in diabetic patients: A consequence of a multidisciplinary foot care team approach?
24. Adjunctive hyperbaric oxygen therapy in treatment of diabetic foot wounds
25. Hyperbaric oxygen as a signal transducer: Upregulation of platelet derived growth factorbeta receptor in the presence of HBO2 and PDGF
26. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers
27. Hyperbaric oxygen therapy: A physiological approach to selected wound healing
28. Hyperbaric oxygen therapy in the diabetic foot
29. Hyperbaric oxygen in diabetic gangrene treatment
30. Adjunctive systemic hyperbaric oxygen therapy in treatment of prevalently ischemic diabetic foot ulcer: A randomized study
31. Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: Prognostic determinants for major amputation
32. Consensus Development Conference of Diabetic Foot Wound Care
33. Treatment with a human skin equivalent, Graftskin (Apligraf), improves healing rate in diabetic foot ulcers
34. Care of venous leg ulcers
35. Apligraf (Graftskin) in conjunction with hyperbaric oxygen therapy effectively treats chronic venous leg ulcers: A case series
36. The diabetic neuropathic ulcer: An overview
37. The role of growth factors in wound healing
38. Platelet-derived growth factor
39. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers
40. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: A phase III, randomized, placebo-controlled, double-blind study
41. Patient-level estimates of the cost of complications in diabetes in a managed-care population
42. Direct medical costs of complications resulting from type 2 diabetes in the US
43. Cost of diabetes-related amputations in minorities
44. Salvage of the problem wound and potential amputation with wound care and adjuncrive hyperbaric oxygen therapy: An economic analysis
45. Prevention of amputation by diabetic education